Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
In the US, the most significant morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) is embolic stroke, with 90% of thrombus originating from the left atrial appendage (LAA). Anticoagulation is the preferred treatment for the prevention of stroke in NVAF patients, but clin...
Guardado en:
Autores principales: | Mark S Slaughter, Gretel Monreal, Steven C Koenig, Guruprasad A Giridharan, Landon H Tompkins, Jorge H Jimenez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0d2079cc2ab4300be0cd83b6ba15e11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu Yaowu, et al.
Publicado: (2021) -
Device-Related Thrombus After Left Atrial Appendage Closure
por: Philippe Garot, et al.
Publicado: (2019) -
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
por: Toshiaki Isogai, et al.
Publicado: (2021) -
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility
por: Swaans MJ, et al.
Publicado: (2016) -
Impact of left atrial appendage morphology on thrombus formation after successful left atrial appendage occlusion: Assessment with cardiac-computed-tomography
por: Wulf Dieker, et al.
Publicado: (2018)